HR 3155
108th Congress
House
Fair Balance Prescription Drug Advertisement Act of 2003
Official title: To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain infor… Show full official titleShow less
Official title: To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, and to amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements.
Taxation
CommerceConsumer educationCostsDeceptive advertising
More subjectsShow fewer subjects
Drug advertisingDrug industryDrugsGovernment Operations and PoliticsGovernment paperworkHealthIncome taxTax deductions
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 6, 2003
Referred to the Subcommittee on Health.
Sep 23, 2003
Sponsor introductory remarks on measure. (CR E1862-1863)
Sep 23, 2003
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 23, 2003
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
Fair Balance Prescription Drug Advertisement Act of 2003 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H.R. 3155: Fair Balance Prescription Drug Advertisement Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-3155/
"H.R. 3155: Fair Balance Prescription Drug Advertisement Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-3155/.
H.R. 3155, 108th Cong. (2026), https://openamerica.io/bill/108-HR-3155/.
[H.R. 3155: Fair Balance Prescription Drug Advertisement Act of 2003](https://openamerica.io/bill/108-HR-3155/)